FutureChem Co.,Ltd (220100.KQ)

KRW 18200.0

(0.94%)

Inventory Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual inventory in 2023 was 1.37 Billion KRW , up 18.7% from previous year.
  • FutureChem Co.,Ltd's latest quarterly inventory in 2024 Q2 was 1.63 Billion KRW , up 11.56% from previous quarter.
  • FutureChem Co.,Ltd reported annual inventory of 1.15 Billion KRW in 2022, up 5.98% from previous year.
  • FutureChem Co.,Ltd reported annual inventory of 1.09 Billion KRW in 2021, up 6.24% from previous year.
  • FutureChem Co.,Ltd reported quarterly inventory of 1.46 Billion KRW for 2024 Q1, up 6.47% from previous quarter.
  • FutureChem Co.,Ltd reported quarterly inventory of 1.37 Billion KRW for 2023 FY, up 18.7% from previous quarter.

Annual Inventory Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Inventory of FutureChem Co.,Ltd (2023 - 2016)

Year Inventory Inventory Growth
2023 1.37 Billion KRW 18.7%
2022 1.15 Billion KRW 5.98%
2021 1.09 Billion KRW 6.24%
2020 1.02 Billion KRW 26.19%
2019 815.01 Million KRW 41.99%
2018 573.98 Million KRW -52.37%
2017 1.2 Billion KRW 72.09%
2016 700.26 Million KRW 0.0%

Peer Inventory Comparison of FutureChem Co.,Ltd

Name Inventory Inventory Difference
HLB Pharmaceutical Co., Ltd 20.85 Billion KRW 93.41%
CMG Pharmaceutical Co., Ltd. 15.87 Billion KRW 91.342%
Celltrion Pharm, Inc. 100.42 Billion KRW 98.631%
Huons Global Co., Ltd. 121.81 Billion KRW 98.872%
DongKook Pharmaceutical Co., Ltd. 138.34 Billion KRW 99.006%
Enzychem Lifesciences Corporation 14.94 Billion KRW 90.803%
Humedix Co., Ltd. 28.62 Billion KRW 95.198%
Boditech Med Inc. 31.6 Billion KRW 95.651%
EuBiologics Co., Ltd. 13.34 Billion KRW 89.698%
Huons Co., Ltd. 76.59 Billion KRW 98.206%
BNC Korea Co., Ltd. 11.39 Billion KRW 87.936%
AptaBio Therapeutics Inc. - KRW -Infinity%